Home/Filings/4/0001209191-20-002034
4//SEC Filing

Abdollahian Neil 4

Accession 0001209191-20-002034

CIK 0001610618other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:27 PM ET

Size

5.3 KB

Accession

0001209191-20-002034

Insider Transaction Report

Form 4
Period: 2020-01-03
Abdollahian Neil
Chief Business Officer
Transactions
  • Sale

    Common Stock

    2020-01-03$3.42/sh2,340$8,00351,248 total
Footnotes (2)
  • [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  • [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2019.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001678223

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:27 PM ET
Size
5.3 KB